BusinessAXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye IndicationsBy Nasdaq OMXMar 21, 2017, 1:01 PM UTC
BusinessAXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye IndicationsBy Nasdaq OMXMar 21, 2017, 1:01 PM UTC
BusinessCeva and Zoion Pharma Announce Collaboration to Develop Epithelial Sodium Channel Blockers to Treat Veterinary Ocular Surface DiseasesBy Nasdaq OMXJan 19, 2016, 1:00 PM UTC
